26.07.2017 15:40:00

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Meridian Bioscience, Inc. - VIVO

NEW YORK, July 26, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City announces it is investigating Meridian Bioscience, Inc. (NasdaqGS: VIVO)("Meridian" or the "Company") for possible violations of federal securities laws.

Monteverde & Associates PC Logo

The investigation is based on whether Meridian and its executives violated federal securities law by misleading investors by making false and/or misleading statements regarding the Company's business, operational and compliance policies.

Mr. Monteverde would like to personally discuss with you how to potentially recover your monetary losses.

Click here for more information: http://monteverdelaw.com/securities/It is free and there is no cost or obligation to you.

Monteverde & Associates PC is a boutique class action securities and consumer litigation law firm committed that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing.  Monteverde & Associates PC lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave, Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com 
Tel: (212) 971-1341
Attorney Advertising. (C) 2017 Monteverde & Associates PC.  Prior results do not guarantee a similar outcome with respect to any future matter.

 

View original content with multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde--associates-pc-announces-an-investigation-of-meridian-bioscience-inc--vivo-300494486.html

SOURCE Monteverde & Associates PC

Nachrichten zu Meridian Bioscience Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Meridian Bioscience Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!